Skip to main content
logo
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
19.54
-0.73 (-3.60%)
At close: Feb 26, 2026, 4:00 PM EST
18.87
-0.67 (-3.43%)
After-hours: Feb 26, 2026, 7:00 PM EST

Arcus Biosciences Revenue

In the year 2025, Arcus Biosciences had annual revenue of $247.00M, down -4.26%. Arcus Biosciences had revenue of $33.00M in the quarter ending December 31, 2025, with 26.92% growth.

Revenue (ttm)
$247.00M
Revenue Growth
-4.26%
P/S Ratio
9.92
Revenue / Employee
$393,939
Employees
627
Market Cap
2.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025247.00M-11.00M-4.26%
Dec 31, 2024258.00M141.00M120.51%
Dec 31, 2023117.00M5.00M4.46%
Dec 31, 2022112.00M-271.00M-70.76%
Dec 31, 2021383.00M305.00M391.03%
Dec 31, 202078.00M63.00M420.00%
Dec 31, 201915.00M6.65M79.58%
Dec 31, 20188.35M6.94M491.15%
Dec 31, 20171.41M--
Dec 31, 2016---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.00B
Travere Therapeutics490.73M
Adaptive Biotechnologies276.98M
Wave Life Sciences109.23M
Viridian Therapeutics70.79M
Liquidia69.22M
Ascentage Pharma Group International54.52M
Immunome9.68M
Revenue Rankings

RCUS News

More News